BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 16369491)

  • 1. Identification of putative oncogenes in lung adenocarcinoma by a comprehensive functional genomic approach.
    Li R; Wang H; Bekele BN; Yin Z; Caraway NP; Katz RL; Stass SA; Jiang F
    Oncogene; 2006 Apr; 25(18):2628-35. PubMed ID: 16369491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The hepatocyte nuclear factor 3 alpha gene, HNF3alpha (FOXA1), on chromosome band 14q13 is amplified and overexpressed in esophageal and lung adenocarcinomas.
    Lin L; Miller CT; Contreras JI; Prescott MS; Dagenais SL; Wu R; Yee J; Orringer MB; Misek DE; Hanash SM; Glover TW; Beer DG
    Cancer Res; 2002 Sep; 62(18):5273-9. PubMed ID: 12234996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined microarray analysis of small cell lung cancer reveals altered apoptotic balance and distinct expression signatures of MYC family gene amplification.
    Kim YH; Girard L; Giacomini CP; Wang P; Hernandez-Boussard T; Tibshirani R; Minna JD; Pollack JR
    Oncogene; 2006 Jan; 25(1):130-8. PubMed ID: 16116477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amplification and overexpression of the dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 2 (DYRK2) gene in esophageal and lung adenocarcinomas.
    Miller CT; Aggarwal S; Lin TK; Dagenais SL; Contreras JI; Orringer MB; Glover TW; Beer DG; Lin L
    Cancer Res; 2003 Jul; 63(14):4136-43. PubMed ID: 12874018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of genes whose expression is upregulated in lung adenocarcinoma cells in comparison with type II alveolar cells and bronchiolar epithelial cells in vivo.
    Kobayashi K; Nishioka M; Kohno T; Nakamoto M; Maeshima A; Aoyagi K; Sasaki H; Takenoshita S; Sugimura H; Yokota J
    Oncogene; 2004 Apr; 23(17):3089-96. PubMed ID: 14755238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of genes involved in squamous cell carcinoma of the lung using synchronized data from DNA copy number and transcript expression profiling analysis.
    Lo KC; Stein LC; Panzarella JA; Cowell JK; Hawthorn L
    Lung Cancer; 2008 Mar; 59(3):315-31. PubMed ID: 18029052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detailed gene copy number and RNA expression analysis of the 17q12-23 region in primary breast cancers.
    Willis S; Hutchins AM; Hammet F; Ciciulla J; Soo WK; White D; van der Spek P; Henderson MA; Gish K; Venter DJ; Armes JE
    Genes Chromosomes Cancer; 2003 Apr; 36(4):382-92. PubMed ID: 12619162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gain and overexpression of the oncostatin M receptor occur frequently in cervical squamous cell carcinoma and are associated with adverse clinical outcome.
    Ng G; Winder D; Muralidhar B; Gooding E; Roberts I; Pett M; Mukherjee G; Huang J; Coleman N
    J Pathol; 2007 Jul; 212(3):325-34. PubMed ID: 17516585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic classification of lung adenocarcinoma based on array-based comparative genomic hybridization analysis: its association with clinicopathologic features.
    Shibata T; Uryu S; Kokubu A; Hosoda F; Ohki M; Sakiyama T; Matsuno Y; Tsuchiya R; Kanai Y; Kondo T; Imoto I; Inazawa J; Hirohashi S
    Clin Cancer Res; 2005 Sep; 11(17):6177-85. PubMed ID: 16144918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RANTES expression is a predictor of survival in stage I lung adenocarcinoma.
    Moran CJ; Arenberg DA; Huang CC; Giordano TJ; Thomas DG; Misek DE; Chen G; Iannettoni MD; Orringer MB; Hanash S; Beer DG
    Clin Cancer Res; 2002 Dec; 8(12):3803-12. PubMed ID: 12473593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of overexpressed genes in frequently gained/amplified chromosome regions in multiple myeloma.
    Largo C; Alvarez S; Saez B; Blesa D; Martin-Subero JI; González-García I; Brieva JA; Dopazo J; Siebert R; Calasanz MJ; Cigudosa JC
    Haematologica; 2006 Feb; 91(2):184-91. PubMed ID: 16461302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High resolution analysis of genomic aberrations by metaphase and array comparative genomic hybridization identifies candidate tumour genes in lung cancer cell lines.
    Zhu H; Lam DC; Han KC; Tin VP; Suen WS; Wang E; Lam WK; Cai WW; Chung LP; Wong MP
    Cancer Lett; 2007 Jan; 245(1-2):303-14. PubMed ID: 16517066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of genes with correlated patterns of variations in DNA copy number and gene expression level in gastric cancer.
    Yang S; Jeung HC; Jeong HJ; Choi YH; Kim JE; Jung JJ; Rha SY; Yang WI; Chung HC
    Genomics; 2007 Apr; 89(4):451-9. PubMed ID: 17229543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic profiles associated with early micrometastasis in lung cancer: relevance of 4q deletion.
    Wrage M; Ruosaari S; Eijk PP; Kaifi JT; Hollmén J; Yekebas EF; Izbicki JR; Brakenhoff RH; Streichert T; Riethdorf S; Glatzel M; Ylstra B; Pantel K; Wikman H
    Clin Cancer Res; 2009 Mar; 15(5):1566-74. PubMed ID: 19208797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomic and proteomic analyses of vascular endothelial growth factor and insulin-like growth factor-binding protein 3 in lung adenocarcinomas.
    Gharib TG; Chen G; Huang CC; Misek DE; Iannettoni MD; Hanash SM; Orringer MB; Beer DG
    Clin Lung Cancer; 2004 Mar; 5(5):307-12. PubMed ID: 15086970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HOXB2, an adverse prognostic indicator for stage I lung adenocarcinomas, promotes invasion by transcriptional regulation of metastasis-related genes in HOP-62 non-small cell lung cancer cells.
    Inamura K; Togashi Y; Ninomiya H; Shimoji T; Noda T; Ishikawa Y
    Anticancer Res; 2008; 28(4B):2121-7. PubMed ID: 18751384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Profiling of transcripts and proteins modulated by K-ras oncogene in the lung tissues of K-ras transgenic mice by omics approaches.
    Lee S; Kang J; Cho M; Seo E; Choi H; Kim E; Kim J; Kim H; Kang GY; Kim KP; Park YH; Yu DY; Yum YN; Park SN; Yoon DY
    Int J Oncol; 2009 Jan; 34(1):161-72. PubMed ID: 19082487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycoproteomic analysis of WGA-bound glycoprotein biomarkers in sera from patients with lung adenocarcinoma.
    Hongsachart P; Huang-Liu R; Sinchaikul S; Pan FM; Phutrakul S; Chuang YM; Yu CJ; Chen ST
    Electrophoresis; 2009 Apr; 30(7):1206-20. PubMed ID: 19294700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive profiling of 8p11-12 amplification in breast cancer.
    Gelsi-Boyer V; Orsetti B; Cervera N; Finetti P; Sircoulomb F; Rougé C; Lasorsa L; Letessier A; Ginestier C; Monville F; Esteyriès S; Adélaïde J; Esterni B; Henry C; Ethier SP; Bibeau F; Mozziconacci MJ; Charafe-Jauffret E; Jacquemier J; Bertucci F; Birnbaum D; Theillet C; Chaffanet M
    Mol Cancer Res; 2005 Dec; 3(12):655-67. PubMed ID: 16380503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of DNA copy number changes in microdissected serous ovarian cancer tissue using a cDNA microarray platform.
    Tsuda H; Birrer MJ; Ito YM; Ohashi Y; Lin M; Lee C; Wong WH; Rao PH; Lau CC; Berkowitz RS; Wong KK; Mok SC
    Cancer Genet Cytogenet; 2004 Dec; 155(2):97-107. PubMed ID: 15571795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.